Astellas teams up with UK biotech Mogrify on hearing loss project
pharmaphorum
JULY 5, 2022
The new partnership will apply Mogrify’s cellular reprogramming and bioinformatics expertise to try to identify transcription factors – proteins which can turn specific genes on or off – that can be used to generate new cochlear hair cells. An estimated 1.57
Let's personalize your content